Psychotic Disorders - Egypt | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$76.45m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.04%, resulting in a market volume of US$84.58m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$66.11 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Egypt is witnessing significant development and growth.

Customer preferences: Customers in Egypt are increasingly seeking effective treatments and therapies for psychotic disorders. They are becoming more aware of mental health issues and the importance of seeking professional help. As a result, there is a growing demand for psychiatric services and medications that can effectively manage psychotic disorders.

Trends in the market: One of the key trends in the Psychotic Disorders market in Egypt is the increasing availability and accessibility of mental health services. The government has been focusing on improving mental healthcare infrastructure and increasing the number of psychiatric hospitals and clinics across the country. This has made it easier for individuals to seek help and receive appropriate treatment for their psychotic disorders. Another trend in the market is the growing use of digital platforms for mental health support. Telemedicine and online therapy services have gained popularity, especially in remote areas where access to mental healthcare facilities may be limited. These platforms provide a convenient and confidential way for individuals to receive therapy and medication management for their psychotic disorders.

Local special circumstances: Egypt has a relatively high prevalence of mental health disorders, including psychotic disorders. This can be attributed to various factors such as socio-economic stress, political instability, and cultural attitudes towards mental health. The stigma surrounding mental illnesses is slowly diminishing, leading to a greater acceptance of seeking treatment for psychotic disorders.

Underlying macroeconomic factors: The Egyptian economy has been growing steadily, which has had a positive impact on the healthcare sector. Increased government spending on healthcare infrastructure and services has improved access to mental healthcare for individuals with psychotic disorders. Additionally, the rise in disposable income among the middle class has allowed more people to afford private mental healthcare services and medications.In conclusion, the Psychotic Disorders market in Egypt is experiencing significant growth and development due to increasing customer preferences for effective treatments, the availability of mental health services, the use of digital platforms for support, and the improving socio-economic conditions in the country. These factors are driving the market forward and providing individuals with better access to the necessary care and treatment for their psychotic disorders.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.